Exact Mass: 243.92812519999998
Exact Mass Matches: 243.92812519999998
Found 227 metabolites which its exact mass value is equals to given mass value 243.92812519999998
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,3,5-Trichloro-cis,cis-muconate
C6H3Cl3O4 (243.90969280000002)
Clodronate
CH4Cl2O6P2 (243.88602040000004)
Clodronate is only found in individuals that have used or taken this drug. It is a diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. [PubChem]The bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. The exact mechanism of action of clodronate is not known, however it is known that it does not inhibit protein isoprenylation but can be metabolized intracellularly to a β-γ-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Inhibition of the ADP/ATP translocase by the metabolite AppCCl2p is a likely route by which clodronate causes osteoclast apoptosis and inhibits bone resorption. Recently, the slime mold Dictyostelium discoideum was shown to take up bisphosphonates by pinocytosis. In these cells, clodronate, but not other pharmacologically active bisphosphonates, was incorporated into adenine nucleotides, which could potentially explain why this bisphosphonate sometimes seems to act differently than the other bisphosphonates. Clodronate, like all biphosphonates, also binds protein-tyrosine-phosphatase. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
1,2,3,5-Tetrachloro-4-methoxybenzene
Off-odour component of flour, etc. stored in contaminated jute sack
Clodronate
CH4Cl2O6P2 (243.88602040000004)
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
8-Bromo-5-fluoro-2,3-dihydro-4H-chromen-4-one
C9H6BrFO2 (243.95351680000002)
1-(Difluoromethyl)-4-iodo-1H-pyrazole
C4H3F2IN2 (243.93090519999998)
(1,3-dioxolan-2-ylethyl)zinc bromide
C5H9BrO2Zn (243.90773240000001)
2,4-Dichlorobenzenesulfonyl chloride
C6H3Cl3O2S (243.89193480000003)
acetazolamide sodium
C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
5-BROMO-2-CHLOROMETHYL-IMIDAZO[1,2-A]PYRIDINE
C8H6BrClN2 (243.94028459999998)
4-Chlorophenyl phosphorodichloridate
C6H4Cl3O2P (243.90145040000002)
6-bromo-2-(chloromethyl)imidazo[1,2-a]pyridine
C8H6BrClN2 (243.94028459999998)
5-(5-Bromothiazol-2-yl)-1-methyl-1H-[1,2,4]triazole
(S)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
3-BROMO-5-CHLORO-6-METHYL-7-AZAINDOLE
C8H6BrClN2 (243.94028459999998)
3,5-Dichlorobenzenesulfonyl chloride
C6H3Cl3O2S (243.89193480000003)
sodium molybdate dihydrate
A hydrate that is the dihydrate form of sodium molybdate.
(2E)-3-(3-Bromo-4-fluorophenyl)acrylic acid
C9H6BrFO2 (243.95351680000002)
(S)-(-)-3,7-DIMETHYL-6-OCTENOICACID
C5H9BrO2Zn (243.90773240000001)
2,6-DICHLOROBENZENESULFONYL CHLORIDE
C6H3Cl3O2S (243.89193480000003)
(R)-(+)-3-Methoxy-2-methyl-3-oxopropylzinc bromide solution
C5H9BrO2Zn (243.90773240000001)
7-CHLORO-3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]THIAZINE-6-CARBOXYLIC ACID
4-Bromo-2-chloro-1-methyl-1H-benzimidazole
C8H6BrClN2 (243.94028459999998)
(R)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
2-CHLORO-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBONYL CHLORIDE
C6HCl2F3N2O (243.94180319999998)
2,5-DIAMINO-1,4-BENZENEDITHIOL DIHYDROCHLORIDE
C6H10Cl2N2S2 (243.96624400000002)
3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole
C7H5BrN2OS (243.93059399999999)
3-Chloro-6-methylbenzothiophene-2-carbonyl chloride
Tetraamminepalladium(II) dichloride
H12Cl2N4Pd (243.94737220000002)
4-Bromo-6-chloro-2-methyl-1H-benzo[d]imidazole
C8H6BrClN2 (243.94028459999998)
2,5-DICHLOROBENZENESULFONYL CHLORIDE
C6H3Cl3O2S (243.89193480000003)
7-bromo-2-(chloromethyl)H-imidazo[1,2-a]pyridine
C8H6BrClN2 (243.94028459999998)
4-fluoronaphthalene-1-sulfonyl chloride
C10H6ClFO2S (243.97610580000003)
3-Bromo-6-chloro-4-methyl-1H-pyrrolo[2,3-b]pyridine
C8H6BrClN2 (243.94028459999998)
3-Bromo-4-chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine
C8H6BrClN2 (243.94028459999998)
1H-Pyrrolo[2,3-b]pyridine, 4-bromo-5-chloro-2-Methyl-
C8H6BrClN2 (243.94028459999998)
1-Bromo-2-chloro-3,4,5-trifluorobenzene
C6HBrClF3 (243.89022319999998)
2-[(4-chlorophenyl)sulfonyl]-2-hydroxyiminoacetonitrile
methyl 3-chloro-6-fluorobenzo(b)thiophe&
C10H6ClFO2S (243.97610580000003)
Arsonium,(2-hydroxyethyl)trimethyl-, bromide (1:1)
C5H14AsBrO (243.94439139999997)
Domiodol
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent
2,3-Dichlorobenzenesulfonyl chloride
C6H3Cl3O2S (243.89193480000003)
3,4-Dichlorobenzenesulfonyl chloride
C6H3Cl3O2S (243.89193480000003)
5-Bromo-2-chloro-4,6-dimethylnicotinonitrile
C8H6BrClN2 (243.94028459999998)
2-chlorophenyl phosphorodichloridate
C6H4Cl3O2P (243.90145040000002)
1-BroMo-3-chloro-2,4,5-trifluorobenzene[3-chloro-2,4,5-trifluorobroMobenzene]
C6HBrClF3 (243.89022319999998)
4-Bromo-6-chloro-2H-benzo[d]imidazol-2-one
C7H2BrClN2O (243.90390119999998)
6-Fluoro-2-naphthalenesulfonyl chloride
C10H6ClFO2S (243.97610580000003)
1H-BENZIMIDAZOLE, 6-BROMO-2-(CHLOROMETHYL)-
C8H6BrClN2 (243.94028459999998)
2-Amino-5-bromobenzo[d]thiazole 3-oxide
C7H5BrN2OS (243.93059399999999)
Ferric nitrilotriacetate
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
Clodronic Acid
CH4Cl2O6P2 (243.88602040000004)
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
2-Chloro-2-(2,4-dichloro-5-oxofuran-2-yl)acetic acid
C6H3Cl3O4 (243.90969280000002)